Séverine Bompoint

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +17

Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease

Clara K Chow, Julie Redfern, Graham S. Hillis et al. · JAMA · 2015 · 719 citations

Medicine, Cardiology, Health Behavior +17

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

Kenneth W. Mahaffey, Meg Jardine, Séverine Bompoint et al. · Circulation · 2019 · 288 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk

Anushka Patel, Alan Cass, David Peiris et al. · European Journal of Preventive Cardiology · 2014 · 181 citations · Full text

Pharmacy, Pharmacotherapy, Preventive Medicine +17

Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial

Caitlin Jones, Richard O. Day, Bart W. Koes et al. · The Lancet · 2023 · 158 citations · Full text

Medicine, Anesthesiology, Pharmacotherapy +13